(S)-3-[1-METHYLPYRROLIDIN-2-YL]PYRIDINE, ANALOGUES THEREOF, PRECURSORS THEREOF, OR ITS DERIVATIVES, FOR THE USE AS A PHARMACEUTICAL IN FORM OF A HOMOGENEOUS, VISCOUS, SEMI-SOLID TOPICAL MEDICATION AND TOPICAL MEDICATION - Patent 4069191

(19)

(11)

EP 4 069 191 A1

(12)

(43)	Date of publication:
	12.10.2022 Bulletin 2022/41

(21)	Application number: 20820563.3

(22)	Date of filing: 02.12.2020

(51)

International Patent Classification (IPC):

A61K 9/00^(2006.01)

A61K 31/00^(2006.01)

(52)	Cooperative Patent Classification (CPC):
	A61K 9/0014; A61K 31/4439

(86)	International application number:
	PCT/IB2020/061400

(87)	International publication number:
	WO 2021/111339 (10.06.2021 Gazette 2021/23)

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
	Designated Extension States:
	BA ME
	Designated Validation States:
	KH MA MD TN

(30)

Priority:

02.12.2019 LU 101520

(71)	Applicant: Solis Herrera, Arturo
	CP20000 Aguascalientes (MX)

(72)	Inventor:
	Solis Herrera, Arturo CP20000 Aguascalientes (MX)

(74)	Representative: Bals & Vogel Patentanwälte PartGmbB
	Konrad-Zuse-Str. 4 44801 Bochum 44801 Bochum (DE)

(54)	(S)-3-[1-METHYLPYRROLIDIN-2-YL]PYRIDINE, ANALOGUES THEREOF, PRECURSORS THEREOF, OR ITS DERIVATIVES, FOR THE USE AS A PHARMACEUTICAL IN FORM OF A HOMOGENEOUS, VISCOUS, SEMI-SOLID TOPICAL MEDICATION AND TOPICAL MEDICATION